SUPRIYASupriya Lifescience Ltd.
Supriya Lifescience Q2 FY27 Results: Standalone Net Profit ₹29.25 Crore on Total Income of ₹209 Crore
- Earnings
- pharmaceutical API manufacturing
Reviewed byKeshav SehgalBlacklitt Research
Supriya Lifescience (NSE: SUPRIYA) reported standalone total income of ₹208.59 crore and net profit of ₹29.25 crore for the quarter ended 30 Sep 2026, it said in a filing on 06 Nov 2026. Net profit fell from ₹50.43 crore in the same quarter a year earlier.
Key highlights
Standalone
The company on its own, without its subsidiaries
- Total income: ₹208.59 crore, up 3.0% YoY and 8.4% QoQ
- Net profit and EPS: ₹29.25 crore, down 42.0% YoY; basic EPS ₹3.63 against ₹6.27
- Tax expense: ₹8.53 crore, against ₹17.89 crore a year earlier
- Depreciation: ₹9.46 crore, up 42.5% YoY
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 208.59 | 202.56 | +3.0% | 192.40 | +8.4% | |
| Revenue from operations | 206.30 | 199.83 | +3.2% | 189.75 | +8.7% |
| Other income | 2.29 | 2.73 | -15.9% | 2.65 | -13.4% |
| 29.25 | 50.43 | -42.0% | 24.04 | +21.7% | |
| Profit before tax | 37.78 | 68.32 | -44.7% | 40.79 | -7.4% |
| Finance costs | 0.46 | 0.42 | +10.1% | 0.37 | +22.2% |
| Depreciation | 9.46 | 6.64 | +42.5% | 8.94 | +5.8% |
| Tax expense | 8.53 | 17.89 | -52.3% | 16.75 | -49.1% |
| Net profit margin | 14.02% | 24.90% | -10.87 pp | 12.50% | +1.53 pp |
| EPS, basic (₹) | 3.63 | 6.27 | -42.1% | 2.99 | +21.4% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Net profit fell faster than income. Total income rose 3.0% to ₹208.59 crore, but net profit fell 42.0% to ₹29.25 crore, and profit before tax fell 44.7% to ₹37.78 crore. The gap sits below revenue: revenue from operations grew 3.2%, while other income fell 15.9% to ₹2.29 crore.
Tax took a smaller share of profit this quarter. Tax expense of ₹8.53 crore is 22.6% of profit before tax of ₹37.78 crore, against ₹17.89 crore on ₹68.32 crore a year earlier, a rate of 26.2%. Other income of ₹2.29 crore is 6.1% of profit before tax, so the quarter's profit rests almost entirely on operations.
Depreciation rose 42.5% to ₹9.46 crore, and finance costs of ₹0.46 crore are only 0.2% of total income, so borrowing is not a material drag on the quarter. The company reports no borrowings on its balance sheet at 30 Sep 2026. The statement shows no exceptional item for the quarter, while the year ended 31 Mar 2026 shows one of ₹0.46 crore.
Against the June quarter, net profit rose 21.7% while profit before tax fell 7.4%. The notes say material intended for export in the first quarter of FY 2026-27 was detained by Customs in transit and was exported on 02 Oct 2026 after clearance. The notes do not say what effect the detention had on the quarter's results.
Inference
The company says it has no subsidiary, associate or joint venture as on 30 Sep 2026. The board approved the results on 06 Nov 2026, and the auditor's limited review found nothing to indicate a material misstatement.
Dividend paid in the half year was ₹8.05 crore. The filing does not say whether any dividend has been declared for FY 2026-27. The reason for the fall in net profit from the year-earlier quarter, and the reason for the rise in other expenditure and employee costs, are not stated in the filing.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.